Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome

•As suggested by reviewer, in the section 3.5, we have changed the P=0.0083. Please see the change below.•“The results indicated that TTTY15-USP9Y score (regardless of its coding) (p=0.0083 and <0.0001, respectively)”.•As suggested by reviewer, in the section 3.5, we have added one sentence “The results from the new model indicated that TTTY15-USP9Y score (regardless of its coding) remained independently prognostic (p=0.0034 and <0.0001, respectively).” prior to the last sentence.